Midregional proadrenomedullin for prognosis in community-acquired pneumonia: A systematic review

Respiratory Medicine

Volumn 108, Issue 11, 2014, Pages 1569-1580

  Cavallazzi, Rodrigo ^a   El Kersh, Karim ^a   Abu Atherah, Emran ^a   Singh, Sonal ^b   Loke, Yoon K ^c   Wiemken, Timothy ^a   Ramirez, Julio ^a  

^a University of Louisville School of Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Epidemiology; Meta analysis; Pneumonia; Prognosis

Indexed keywords

PROADRENOMEDULLIN; ADRENOMEDULLIN; BIOLOGICAL MARKER; PROTEIN PRECURSOR;

ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; PNEUMONIA; STATISTICAL BIAS;

ADRENOMEDULLIN; BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; PNEUMONIA; PROGNOSIS; PROTEIN PRECURSORS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84922439923     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2014.09.018     Document Type: Review

References (35)

1. J. Struck, C. Tao, and N.G. Morgenthaler Identification of an adrenomedullin precursor fragment in plasma of sepsis patients Peptides 25 Suppl. 8 2004 1369 1372
2. N.G. Morgenthaler, J. Struck, and C. Alonso Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 Suppl. 10 2005 1823 1829
3. W.C. Albrich, F. Dusemund, and K. Ruegger Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm BMC Infect Dis 11 2011 112 2334-11-112
4. S. Bello, A.B. Lasierra, and E. Minchole Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology Eur Respir J 39 Suppl. 5 2012 1144 1155
5. M. Christ-Crain, N.G. Morgenthaler, and D. Stolz Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397 Crit Care. 10 Suppl. 3 2006 R96
6. C. Guertler, B. Wirz, and M. Christ-Crain Inflammatory responses predict long-term mortality risk in community-acquired pneumonia Eur Respir J 37 Suppl. 6 2011 1439 1446
7. S. Kruger, S. Ewig, and S. Giersdorf Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: results from the German Competence Network, CAPNETZ Am J Respir Crit Care Med 182 Suppl. 11 2010 1426 1434
8. A.M. Neill, I.R. Martin, and R. Weir Community acquired pneumonia: aetiology and usefulness of severity criteria on admission Thorax 51 Suppl. 10 1996 1010 1016
9. A. Capelastegui, P.P. Espana, and J.M. Quintana Validation of a predictive rule for the management of community-acquired pneumonia Eur Respir J 27 Suppl. 1 2006 151 157
10. W.S. Lim, M.M. van der Eerden, and R. Laing Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Thorax 58 Suppl. 5 2003 377 382
11. D.G. Altman Systematic reviews of evaluations of prognostic variables BMJ. 323 Suppl. 7306 2001 224 228
12. P.F. Whiting, A.W. Rutjes, and M.E. Westwood QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 155 Suppl. 8 2011 529 536
13. H. Reitsma, A. Rutjes, and P. Whiting Assessing methodological quality 2009
14. S. Golder, Y.K. Loke, and M. Bland Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview PLoS Med 8 Suppl. 5 2011 e1001026
15. J.A. Hanley, and B.J. McNeil The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 Suppl. 1 1982 29 36
16. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 Suppl. 3 1986 177 188
17. Review manager (RevMan) [Computer program] 2012 Nordic Cochrane Centre, The Cochrane Collaboration 5.2
18. M. Sarda Sanchez, J.C. Hernandez, and S. Hernandez-Bou Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study BMC Res Notes 5 2012 363 0500-5-363
19. W.C. Albrich, K. Ruegger, and F. Dusemund Optimised patient transfer using an innovative multidisciplinary assessment in Kanton Aargau (OPTIMA I): an observational survey in lower respiratory tract infections Swiss Med Wkly 141 2011 w13237
20. W.C. Albrich, K. Ruegger, and F. Dusemund Biomarker-enhanced triage in respiratory infections: a proof-of-concept feasibility trial Eur Respir J 42 Suppl. 4 2013 1064 1075
21. O. Cinar, E. Cevik, and A. Acar Evaluation of mid-regional pro-atrial natriuretic peptide, procalcitonin, and mid-regional pro-adrenomedullin for the diagnosis and risk stratification of dyspneic ED patients Am J Emerg Med 30 Suppl. 9 2012 1915 1920
22. O. Hartmann, P. Schuetz, and W.C. Albrich Time-dependent Cox regression: serial measurement of the cardiovascular biomarker proadrenomedullin improves survival prediction in patients with lower respiratory tract infection Int J Cardiol 161 Suppl. 3 2012 166 173
23. F. Travaglino, B. De Berardinis, and L. Magrini Utility of procalcitonin (PCT) and mid regional pro-adrenomedullin (MR-proADM) in risk stratification of critically ill febrile patients in Emergency Department (ED). A comparison with APACHE II score BMC Infect Dis 12 2012 184
24. B. Renaud, P. Schuetz, and Y.E. Claessens Proadrenomedullin improves risk of early admission to ICU score for predicting early severe community-acquired pneumonia Chest 142 Suppl. 6 2012 1447 1454
25. P. Schuetz, N. Friedli, and E. Grolimund Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study Diabetologia 57 Suppl. 2 2014 275 284
26. P. Schuetz, M. Wolbers, and M. Christ-Crain Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections Crit Care 14 Suppl. 3 2010 R106
27. B. Susi, M. Mastropasqua, and M. Mazza Prognostic value of pro adrenomedullin in patients with community-acquired pneumonia in emergency department Clin Chem Lab Med 51 Suppl. 11 2013 eA87
28. D.T. Huang, D.C. Angus, and J.A. Kellum Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia Chest 136 Suppl. 3 2009 823 831
29. E. Bereciartua Urbieta, C. Mar Medina, and A. Capelastegui Sáiz Proteína C reactiva, procalcitonina y proadrenomedulina en la evolución de neumonías hospitalizadas Rev del Lab Clínico. 4 Suppl. 1 2011 23 29
30. M. Kolditz, M. Halank, and B. Schulte-Hubbert Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia Respir Med 106 Suppl. 9 2012 1320 1328
31. B. Suberviola, A. Castellanos-Ortega, and J. Llorca Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community-acquired pneumonia Swiss Med Wkly 142 2012 w13542
32. C. Courtais, N. Kuster, and A.M. Dupuy Proadrenomedullin, a useful tool for risk stratification in high pneumonia severity index score community acquired pneumonia Am J Emerg Med 31 Suppl. 1 2013 215 221
33. A. Julian-Jimenez, J. Timon Zapata, and E.J. Laserna Mendieta Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department Enferm Infecc Microbiol Clin 2013
34. A. Lacoma, A. Bas, and P. Tudela Correlation of inflammatory and cardiovascular biomarkers with pneumonia severity scores Enferm Infecc Microbiol Clin 2013
35. Y.K. Loke, C.S. Kwok, and A. Niruban Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis Thorax 65 Suppl. 10 2010 884 890